The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALPHA METALLURGICAL RESOUR I | COM | 020764106 | 8,630 | 683,300 | SH | DFND | 683,300 | 0 | 0 | ||
| CAESARS ENTERTAINMENT INC NE | COM | 12769G100 | 10,364 | 118,516 | SH | DFND | 118,516 | 0 | 0 | ||
| CUMULUS MEDIA INC | COM CL A | 231082801 | 16,325 | 1,792,000 | SH | DFND | 1,865,292 | 0 | 0 | ||
| DENBURY INC | COM | 24790A101 | 201,425 | 4,206,000 | SH | DFND | 4,206,000 | 0 | 0 | ||
| GOGO INC | NOTE 6.000% 5/1 | 38046CAD1 | 6,574 | 3,750,000 | PRN | DFND | 3,750,000 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 45845PAA6 | 48,407 | 58,808,000 | PRN | DFND | 58,808,000 | 0 | 0 | ||
| IHEARTMEDIA INC | COM CL A | 45174J509 | 55,539 | 3,060,000 | SH | DFND | 3,060,000 | 0 | 0 | ||
| LENSAR INC | COM | 52634L108 | 7,648 | 1,053,389 | SH | DFND | 1,053,389 | 0 | 0 | ||
| PG&E CORP | COM | 69331C108 | 341,814 | 29,189,931 | SH | DFND | 29,189,931 | 0 | 0 | ||
| RETAIL VALUE INC | COM | 76133Q102 | 22,074 | 1,179,800 | SH | DFND | 1,179,800 | 0 | 0 | ||
| STUDIO CITY INTL HLDGS LTD | SPON ADS | 86389T106 | 203,070 | 15,384,103 | SH | DFND | 15,384,103 | 0 | 0 | ||
| VISTRA CORP | COM | 92840M102 | 26,520 | 1,500,000 | SH | DFND | 1,500,000 | 0 | 0 | ||